During a normal monthly reproductive cycle, the endometrial lining of the uterus undergoes a series of changes that make it receptive to the possible arrival and successful implantation of an early-stage embryo. Endometrial receptivity only lasts about 12 hours; under natural conditions it coincides with the time that the early-stage embryo would be expected to arrive at the uterus, if in fact an egg was fertilized that month. It all just happens naturally, without any thought on our part.
For infertile couples who opt for in vitro fertilization (IVF) in an attempt to become pregnant, timing can be critical. If the embryo is introduced into the uterus at a time when the uterus is not receptive, the whole process can end in failure. An IVF procedure can cost tens of thousands of dollars, and its not unheard of for couples to try multiple times without success and without knowing why. One possible reason for multiple failures is that the embryo may not have been introduced into the uterus at precisely the right time. The 12-hour window of maximum receptivity can occur on different days of the cycle in different women, and in the past there was no way to determine it.
But now there's a test to determine the precise moment of maximum endometrial receptivity. It's called the endometrial receptivity array (ERA) test. The test works by analyzing the genetic expression of several hundred of the genes known to be involved in the buildup of the endometrium in preparation for implantation. The period of maximum expression of these genes coincides with the best time for embryo implantation. The test has dramatically improved the odds of a pregnancy for couples who had previously experienced multiple IVF failures.
Saturday, February 11, 2017
Tuesday, February 7, 2017
An Experimental Alzheimer's Drug Fails in a Clinical Trial
A potentially promising drug for the prevention of Alzheimer's disease has failed in a key clinical trial, according to Eli Lilly, the drug's developer. In a study involving more than 2,000 patients with early signs of dementia, the drug, known as solanezumab, failed to prevent the advancement of the cognitive impairment that accompanies dementia and that leads ultimately to Alzheimer's disease.
The results were disappointing, but not all that surprising. So far, no drug has been able to prevent the progression of dementia once it has started. Researchers are reluctantly coming to the conclusion that by the time dementia first becomes apparent, it is already too late to affect the future course of Alzheimer's disease.
Whether solanezumab could prevent the development of dementia if it were given before the first signs of dementia is not known. Sadly, it may never be known. That's because it would be prohibitively expensive to conduct a drug study involving tens of thousands of seemingly normal people, in the hope of observing an effect on the few people among them that will ultimately develop dementia.
So we're at an impasse at the moment. There are several drugs on the market that can reduce (at least temporarily) the symptoms of the dementia associated with Alzheimer's disease, but there are no drugs that can prevent the slow progression of the disease. There aren't even any on the horizon, apparently. Don't expect progress any time soon.
The results were disappointing, but not all that surprising. So far, no drug has been able to prevent the progression of dementia once it has started. Researchers are reluctantly coming to the conclusion that by the time dementia first becomes apparent, it is already too late to affect the future course of Alzheimer's disease.
Whether solanezumab could prevent the development of dementia if it were given before the first signs of dementia is not known. Sadly, it may never be known. That's because it would be prohibitively expensive to conduct a drug study involving tens of thousands of seemingly normal people, in the hope of observing an effect on the few people among them that will ultimately develop dementia.
So we're at an impasse at the moment. There are several drugs on the market that can reduce (at least temporarily) the symptoms of the dementia associated with Alzheimer's disease, but there are no drugs that can prevent the slow progression of the disease. There aren't even any on the horizon, apparently. Don't expect progress any time soon.
Friday, February 3, 2017
Many Primate Species Face Extinction
Our closest living relatives in the animal kingdom, the primates, are in trouble. According to a comprehensive review of primate populations around the world by some 31 scientists from 11 countries, nearly 60% of all primate species are in danger of extinction, and many of the others are in decline. That includes every species of apes and nearly all species of lemurs. The one primate species that still appears to be doing extremely well is humans.
The causes are multiple and predictable. Reduction in habitat due to an expanding human population, changes in primate's habitat due to logging, agriculture, and mining, predation (hunting) by humans, and even climate change are all thought to be contributing factors.
Unfortunately, there aren't any easy solutions on the horizon. Unless action is taken soon, it becomes increasingly likely that some of our primate relatives will disappear from planet Earth, if not within the next few decades, most certainly within the next few centuries. And that would be sad.
The causes are multiple and predictable. Reduction in habitat due to an expanding human population, changes in primate's habitat due to logging, agriculture, and mining, predation (hunting) by humans, and even climate change are all thought to be contributing factors.
Unfortunately, there aren't any easy solutions on the horizon. Unless action is taken soon, it becomes increasingly likely that some of our primate relatives will disappear from planet Earth, if not within the next few decades, most certainly within the next few centuries. And that would be sad.
Friday, January 27, 2017
New Guidelines for the Prevention of Peanut Allergy
An expert panel of scientists meeting under the sponsorship of the National Institute of Allergy and Infectious Diseases has issued new guidelines for the prevention of peanut allergies in young children. The guidelines draw on findings published last year (see this blog, Mar. 9, 2015) which showed that adding peanut proteins to the diet of young children at risk for developing allergies significantly reduced the chances of those children developing peanut allergies by age five. The new guidelines are that infants can be fed peanut-containing foods at any age; as early as they begin taking solid food, in fact.
Some parents are skeptical, and a few are even angry. That's because the previous guidelines were to withhold peanuts from young children in the hope that sensitivity to peanuts could be avoided. According to these parents, this reversal of the guidelines is just more evidence that scientists (and their recommendations) shouldn't be trusted.
But the reality is that we try to make rational choices based on whatever information we have at the time. So when new and better information becomes available (such as the data published last year), we should look carefully at it and change our view, if warranted. In a nutshell (no pun intended) that is what has happened with the peanut recommendations.
Some parents are skeptical, and a few are even angry. That's because the previous guidelines were to withhold peanuts from young children in the hope that sensitivity to peanuts could be avoided. According to these parents, this reversal of the guidelines is just more evidence that scientists (and their recommendations) shouldn't be trusted.
But the reality is that we try to make rational choices based on whatever information we have at the time. So when new and better information becomes available (such as the data published last year), we should look carefully at it and change our view, if warranted. In a nutshell (no pun intended) that is what has happened with the peanut recommendations.
Tuesday, January 24, 2017
2016 was the Hottest Year on Record
2016 was the hottest year on record and the third consecutive year of record temperatures, according to climate scientists. Furthermore, the rate of temperature change seems to be accelerating.
Nearly all climate models conclude that the most likely cause of global warming is rising levels of atmospheric CO2 levels brought about by the burning of fossil fuels. And yet, so far not much has been done about it. The problem (and perhaps the reason that climate deniers continue to deny that global warming is even happening) is that curbing future increases in CO2 will not be easy or cheap as long as we continue to depend on fossil fuels for most of our energy needs.
And so Earth will probably continue to warm up. Sigh.
Nearly all climate models conclude that the most likely cause of global warming is rising levels of atmospheric CO2 levels brought about by the burning of fossil fuels. And yet, so far not much has been done about it. The problem (and perhaps the reason that climate deniers continue to deny that global warming is even happening) is that curbing future increases in CO2 will not be easy or cheap as long as we continue to depend on fossil fuels for most of our energy needs.
And so Earth will probably continue to warm up. Sigh.
Sunday, January 15, 2017
Should "Gene Editing" be Regulated?
The generally accepted definition if a GMO (genetically modified organism) is an organism whose genome has been modified by the addition of one or more genes from another species. Most genetically modified corn, for example, has been modified by the addition of genes from certain bacteria, with the goal of giving the corn either resistance to insect pests or resistance to a common herbicide. Not everyone thinks that GMOs are a good idea, and there have been numerous efforts (some successful, some not) to block their development and widespread use.
Now for a new but related question; how should we feel about "gene editing"; the simple removal of existing genes from an organism, without the addition of foreign genes? It's now possible, due to a recently developed technique (called Crispr) for selectively snipping genes out of DNA at selected locations. Crispr is already being used to produce gene-edited plants of interest, such as potatoes or mushrooms that don't turn brown and soybeans with healthier fatty acids.
Last year Congress passed a law requiring that foods containing GMO ingredients must be labeled as such. However, that labeling requirement apparently doesn't extend to plants that are just gene-edited because currently they fall outside the regulatory authority of the federal agencies that oversee GMOs, such as the Agriculture Department and the Food and Drug Administration.
It'll be interesting to see whether the regulatory agencies ever decide to examine and/or regulate gene editing.
Now for a new but related question; how should we feel about "gene editing"; the simple removal of existing genes from an organism, without the addition of foreign genes? It's now possible, due to a recently developed technique (called Crispr) for selectively snipping genes out of DNA at selected locations. Crispr is already being used to produce gene-edited plants of interest, such as potatoes or mushrooms that don't turn brown and soybeans with healthier fatty acids.
Last year Congress passed a law requiring that foods containing GMO ingredients must be labeled as such. However, that labeling requirement apparently doesn't extend to plants that are just gene-edited because currently they fall outside the regulatory authority of the federal agencies that oversee GMOs, such as the Agriculture Department and the Food and Drug Administration.
It'll be interesting to see whether the regulatory agencies ever decide to examine and/or regulate gene editing.
Friday, January 13, 2017
Does Prevagen Improve Memory?
You've seen the commercials for Prevagen, right? It's a dietary supplement containing a protein derived from jellyfish that (according to the manufacturer) "improves memory and reduces common cognitive problems associated with aging." Trouble is, those claims are bogus, according to both the Federal Trade Commission (FTC) and the New York Attorney General's office. This week the two agencies sued Prevagen's manufacturer, Quincy Bioscience for making false and misleading claims, most notably the claim that Prevagen has been "clinically proven" to work. According to the complaint, the experiments undertaken to prove Prevagen's effectiveness were scientifically invalid because they did not show that Prevagen worked any better than a placebo.
No big deal, you say? Well, if you give people memory tests over time, you'd expect some improvement just from test familiarity alone. That's why it's so important to compare the experimental (Prevagen) group to a control group (a group given a fake pill, or placebo), using valid statistical methods.
Prevagen can cost upwards of $60 for a 30-pill bottle. According to the FTC, about $165 million a year is spent on the supplement. That's a lot for an untested cure.
Quincy Bioscience has responded to the lawsuit with a statement that says, in part, that Prevagen hasn't been shown to harm anyone (which is beside the point), and that "hundreds of thousands" of people tell them that Prevagen works and improves their lives. The latter statement, of course, is unscientific and unverifiable.
No big deal, you say? Well, if you give people memory tests over time, you'd expect some improvement just from test familiarity alone. That's why it's so important to compare the experimental (Prevagen) group to a control group (a group given a fake pill, or placebo), using valid statistical methods.
Prevagen can cost upwards of $60 for a 30-pill bottle. According to the FTC, about $165 million a year is spent on the supplement. That's a lot for an untested cure.
Quincy Bioscience has responded to the lawsuit with a statement that says, in part, that Prevagen hasn't been shown to harm anyone (which is beside the point), and that "hundreds of thousands" of people tell them that Prevagen works and improves their lives. The latter statement, of course, is unscientific and unverifiable.
Subscribe to:
Posts (Atom)